Published in J Gen Virol on June 01, 1990
Enteroviral RNA sequences detected by polymerase chain reaction in muscle of patients with postviral fatigue syndrome. BMJ (1991) 3.65
Persistence of viral RNA in mouse brains after recovery from acute alphavirus encephalitis. J Virol (1992) 1.51
The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart (2001) 1.51
Immunopathology of the human pancreas in type-I diabetes. Semin Immunopathol (2010) 1.04
Lymphocyte subset differences in patients with chronic fatigue syndrome, multiple sclerosis and major depression. Clin Exp Immunol (2005) 1.02
The role of enterovirus in chronic fatigue syndrome. J Clin Pathol (2005) 1.02
Distinct pathogenic effects of group B coxsackieviruses on human glomerular and tubular kidney cells. J Virol (1997) 1.01
Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells. J Virol (2000) 1.00
Susceptibility of human bone marrow cells and hematopoietic cell lines to coxsackievirus B3 infection. J Virol (1996) 0.92
High prevalence of enteroviral genomic sequences in myocardium from cases of endemic cardiomyopathy (Keshan disease) in China. Heart (2000) 0.86
A single coxsackievirus B2 capsid residue controls cytolysis and apoptosis in rhabdomyosarcoma cells. J Virol (2010) 0.85
Persistent poliovirus infection in mouse motoneurons. J Virol (1997) 0.82
Persistence of virus and viral genome in myocardium after coxsackievirus B3-induced murine myocarditis. Clin Exp Immunol (1994) 0.80
Biochemical and muscle studies in patients with acute onset post-viral fatigue syndrome. J Clin Pathol (1993) 0.78
Interactions between multiple genetic determinants in the 5' UTR and VP1 capsid control pathogenesis of chronic post-viral myopathy caused by coxsackievirus B1. Virology (2007) 0.78
Immune responsiveness in chronic fatigue syndrome. Postgrad Med J (1992) 0.75
Functional consequences of RNA 5' terminal deletions on coxsackievirus B3 RNA replication and ribonucleoprotein complex formation. J Virol (2017) 0.75
Clinical assessment of gestational age in the newborn infant. J Pediatr (1970) 16.08
A report--chronic fatigue syndrome: guidelines for research. J R Soc Med (1991) 7.70
Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13
Conservation and variation in Orthopoxvirus genome structure. J Gen Virol (1979) 3.83
Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet (1986) 2.68
The failing heart. Nature (2002) 2.66
Postviral fatigue syndrome: persistence of enterovirus RNA in muscle and elevated creatine kinase. J R Soc Med (1988) 2.60
Deletions in the survival motor neuron gene on 5q13 in autosomal recessive spinal muscular atrophy. Hum Mol Genet (1995) 2.59
Predictive value of cranial ultrasound in the newborn baby: a reappraisal. Lancet (1985) 2.37
Mutations in the nebulin gene associated with autosomal recessive nemaline myopathy. Proc Natl Acad Sci U S A (1999) 2.27
Drug-induced myopathies in man. Lancet (1978) 2.25
Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome. Circulation (2001) 2.24
Developmental and neurological progress of preterm infants with intraventricular haemorrhage and ventricular dilatation. Arch Dis Child (1982) 2.12
Cerebral structure and intraventricular haemorrhage in the neonate: a real-time ultrasound study. Arch Dis Child (1981) 2.07
Enterovirus replication in valvular tissue from patients with chronic rheumatic heart disease. Eur Heart J (2002) 1.98
Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest (2000) 1.91
Dermatomyositis, polymyositis, and Coxsackie-B-virus infection. Lancet (1987) 1.80
Acute cerebral oedema induced by methotrexate. BMJ (1989) 1.79
Association of viral genome with graft loss in children after cardiac transplantation. N Engl J Med (2001) 1.78
Genomic variation and gene conversion in spinal muscular atrophy: implications for disease process and clinical phenotype. Am J Hum Genet (1997) 1.74
Detection of microorganisms in the tracheal aspirates of preterm infants by polymerase chain reaction: association of adenovirus infection with bronchopulmonary dysplasia. Pediatr Res (2000) 1.72
Optimality score for the neurologic examination of the infant at 12 and 18 months of age. J Pediatr (1999) 1.72
Chaos in classification of the spinal muscular atrophies of childhood. Neuromuscul Disord (1991) 1.61
Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy. Muscle Nerve (1982) 1.59
Screening for mitochondrial cytopathies: the sub-anaerobic threshold exercise test (SATET). J Neurol Neurosurg Psychiatry (1989) 1.56
Ultrasound imaging in the diagnosis of muscle disease. J Pediatr (1982) 1.53
Prenatal diagnosis in Duchenne muscular dystrophy: Salvage of normal male fetus. Lancet (1978) 1.52
Restriction endonuclease analysis of red cowpox virus and its white pock variant. J Gen Virol (1979) 1.52
Neurological presentations of hypothyroidism: the importance of slow relaxing reflexes. J R Soc Med (1995) 1.51
Glycine and neurodegenerative disease. Lancet (1991) 1.51
Increased expression of HLA ABC class I antigens by muscle fibres in Duchenne muscular dystrophy, inflammatory myopathy, and other neuromuscular disorders. Lancet (1985) 1.51
Colonic perforation after exchange transfusion. Br Med J (1968) 1.50
Enterovirus persistence and myocardial damage detected by 111In-monoclonal antimyosin antibodies in patients with dilated cardiomyopathy. Eur Heart J (1996) 1.48
A new group (type 3) of Mycobacterium celatum isolated from AIDS patients in the London area. Int J Syst Bacteriol (1995) 1.45
Cross-innervated mammalian skeletal muscle: histochemical, physiological and biochemical observations. J Physiol (1967) 1.45
Pathology of experimentally re-innervated skeletal muscle. J Neurol Neurosurg Psychiatry (1967) 1.44
Exercise responses and psychiatric disorder in chronic fatigue syndrome. BMJ (1995) 1.43
Carrier detection and genetic counselling in Duchenne dystrophy. Dev Med Child Neurol (1975) 1.42
Gold-induced neuroencephalopathy responding to dimercaprol. Lancet (1991) 1.42
How primitive is the Moro reflex? Eur J Paediatr Neurol (1997) 1.40
Exon skipping and translation in patients with frameshift deletions in the dystrophin gene. Am J Hum Genet (1993) 1.40
Histological surprise: callosal tuberculoma presenting as malignant glioma. J Neurol Neurosurg Psychiatry (1997) 1.40
Hemorrhagic periventricular leukomalacia in the neonate: a real-time ultrasound study. Pediatrics (1983) 1.39
Nature of the mononuclear infiltrate and the mechanism of muscle damage in juvenile dermatomyositis and Duchenne muscular dystrophy. J Neurol Sci (1990) 1.39
Management of children with non-organic (hysterical) disorders of motor function. Dev Med Child Neurol (1976) 1.36
End-stage dilated cardiomyopathy. Persistence of enterovirus RNA in myocardium at cardiac transplantation and lack of immune response. Circulation (1989) 1.36
Detection of pathological change in dystrophic muscle with B-scan ultrasound imaging. Lancet (1980) 1.36
Deficiency of the human mitochondrial transcription factor h-mtTFA in infantile mitochondrial myopathy is associated with mtDNA depletion. Hum Mol Genet (1994) 1.35
Chloroquine-induced cytosomes with curvilinear profiles in muscle. Muscle Nerve (1979) 1.34
Continuous EEG monitoring of neonatal seizures: diagnostic and prognostic considerations. Arch Dis Child (1989) 1.32
The genetic status of mothers of isolated cases of Duchenne muscular dystrophy. J Med Genet (1983) 1.32
Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation (1994) 1.31
Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy. J Med Genet (1989) 1.30
Enzyme histochemistry of skeletal muscle. J Neurol Neurosurg Psychiatry (1965) 1.29
Paramyotonia congenita: the R1448P Na+ channel mutation in adult human skeletal muscle. Ann Neurol (1996) 1.28
Letter: Standardization of the E.S.R. Br Med J (1974) 1.28
Congenital centronuclear (myotubular) myopathy. A clinical, pathological and genetic study in eight children. Brain (1985) 1.27
Measurements of muscle strength and performance in children with normal and diseased muscle. Arch Dis Child (1976) 1.26
Expression of class I and class II MHC antigens in neuromuscular diseases. J Neurol Sci (1989) 1.25
A balanced de novo X/autosome translocation in a girl with manifestations of Lowe syndrome. Am J Med Genet (1986) 1.22
Peripheral neuropathy in Cockayne's syndrome. Arch Dis Child (1970) 1.21
The myotubular myopathies: differential diagnosis of the X linked recessive, autosomal dominant, and autosomal recessive forms and present state of DNA studies. J Med Genet (1995) 1.21
Screening for Duchenne muscular dystrophy. Arch Dis Child (1976) 1.21
A role for collagen in the pathogenesis of muscular dystrophy? Nature (1980) 1.19
Nemaline myopathy: report of a fatal case, with histochemical and electron microscopic studies. Brain (1967) 1.19
Central core disease of muscle with focal wasting. J Neurol Neurosurg Psychiatry (1965) 1.18
Viral infection of the myocardium in endocardial fibroelastosis. Molecular evidence for the role of mumps virus as an etiologic agent. Circulation (1997) 1.17
Clinical phenotype in congenital muscular dystrophy: correlation with expression of merosin in skeletal muscle. Neuromuscul Disord (1995) 1.17
Management of muscular dystrophy. Pharmacological and physical aspects. Br Med Bull (1980) 1.17
Intellect and behaviour in Duchenne muscular dystrophy. Dev Med Child Neurol (1981) 1.15
Nuclear magnetic resonance imaging of the brain in children. Br Med J (Clin Res Ed) (1982) 1.15
Night-time nasal ventilation in neuromuscular disease. Lancet (1990) 1.14
Real-time ultrasound imaging of muscles. Muscle Nerve (1988) 1.14
DNA deletions in mild and severe Becker muscular dystrophy. Hum Genet (1987) 1.14
Autosomal recessive inheritance of RYR1 mutations in a congenital myopathy with cores. Neurology (2002) 1.14
Segmented arrangement of Borrelia duttonii DNA and location of variant surface antigen genes. J Gen Microbiol (1988) 1.13
X;autosome translocations in females with Duchenne or Becker muscular dystrophy. Nature (1986) 1.12
Dominantly inherited peroneal muscular atrophy (hereditary motor and sensory neuropathy type I) in infancy and childhood. Muscle Nerve (1981) 1.12
Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation (1999) 1.11
Cytochrome c oxidase deficiency associated with the first stop-codon point mutation in human mtDNA. Am J Hum Genet (1998) 1.11
The central nervous system in Duchenne muscular dystrophy. Brain (1969) 1.11
The genome structure of cowpox virus white pock variants. J Gen Virol (1984) 1.11
Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: diagnosis using the polymerase chain reaction. Circulation (1997) 1.10
Dystrophin in frameshift deletion patients with Becker muscular dystrophy. Am J Hum Genet (1992) 1.09
Prenatal prediction of spinal muscular atrophy. J Med Genet (1992) 1.09
Dystrophin-related protein, utrophin, in normal and dystrophic human fetal skeletal muscle. Histochem J (1993) 1.08
Chromosome 15 in Prader-Willi syndrome. Dev Med Child Neurol (1985) 1.08
Letter: Failure of "dystrophic" neurones to support functional regeneration of normal or dystrophic muscle in culture. Nature (1973) 1.07
Comparison of white pock (h) mutants of monkeypox virus with parental monkeypox and with variola-like viruses isolated from animals. Nature (1980) 1.07
Clinical and EEG response to anticonvulsants in neonatal seizures. Arch Dis Child (1989) 1.06
Lactate responses to exercise in chronic fatigue syndrome. J Neurol Neurosurg Psychiatry (1994) 1.05
Continuous 4-channel EEG monitoring: a guide to interpretation, with normal values, in preterm infants. Neuropediatrics (1987) 1.05
Collagen types in neuromuscular diseases. J Neurol Sci (1982) 1.05
Late onset muscular dystrophy with cerebral white matter changes due to partial merosin deficiency. Neuromuscul Disord (1997) 1.04